Yoo Jin Na

1.2k total citations
37 papers, 900 citations indexed

About

Yoo Jin Na is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yoo Jin Na has authored 37 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Yoo Jin Na's work include Autophagy in Disease and Therapy (8 papers), Hedgehog Signaling Pathway Studies (6 papers) and Cancer-related Molecular Pathways (5 papers). Yoo Jin Na is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Hedgehog Signaling Pathway Studies (6 papers) and Cancer-related Molecular Pathways (5 papers). Yoo Jin Na collaborates with scholars based in South Korea, Japan and United States. Yoo Jin Na's co-authors include Sang Cheul Oh, Jung Lim Kim, Yoon A Jeong, Dae-Hee Lee, Seong Hye Park, Min Jee Jo, Soyeon Jeong, Bo Ram Kim, Hye Kyeong Yun and Dae Yeong Kim and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Yoo Jin Na

36 papers receiving 891 citations

Peers

Countries citing papers authored by Yoo Jin Na

Since Specialization

Citations

This map shows the geographic impact of Yoo Jin Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoo Jin Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoo Jin Na more than expected).

Fields of papers citing papers by Yoo Jin Na

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoo Jin Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoo Jin Na. The network helps show where Yoo Jin Na may publish in the future.

Co-authorship network of co-authors of Yoo Jin Na

This figure shows the co-authorship network connecting the top 25 collaborators of Yoo Jin Na. A scholar is included among the top collaborators of Yoo Jin Na based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoo Jin Na. Yoo Jin Na is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010–2021): a retrospective study 2024 ·Journal of Gynecologic Oncology ·Yoo Jin Na, (unknown), (unknown), (unknown), (unknown), Soo Young Hur, Sang-Mi Ryou	2
2	Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Young Rock Jang, Ji Yeon Lee, Jae‐Hoon Ko, Jee‐Young Lee, (unknown), (unknown), (unknown), Miri Hyun, Hyun Ah Kim, Soyoon Hwang, Sang-Mi Ryou, Yoo Jin Na, Joo-Yeon Lee, Changhee Lee, Nan Young Lee, (unknown), Ki Tae Kwon, Jin Yong Kim, Kyong Ran Peck	3
3	Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation? 2022 ·Frontiers in Medicine ·(unknown), Jeong‐Sun Yang, Jae‐Hoon Ko, Myungsun Lee, (unknown), Sehee Park, (unknown), (unknown), Jung‐Min Lee, Yoo Jin Na, Byoung Kwon Park, Hyungjin Kim, Young Ho Lee, (unknown), Kyungmin Huh, Sun Young Cho, Cheol‐In Kang, Doo Ryeon Chung, Kyong Ran Peck	4
4	Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma 2020 ·Theranostics ·Phei Er Saw, Xiaoding Xu, Bo Kang, Jungsul Lee, Yeo Song Lee, Chungyeul Kim, Hyungsin Kim, Shin‐Hyuk Kang, Yoo Jin Na, Hong Joo Moon, Joo Han Kim, Youn‐Kwan Park, Won Ki Yoon, Jong Hyun Kim, Taek Hyun Kwon, Chulhee Choi, Sangyong Jon, Kyuha Chong	27
5	Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells 2020 ·The Korean Journal of Internal Medicine ·Yoo Jin Na, (unknown), Dae Sik Kim, Dae‐Hee Lee, Sang Cheul Oh, Chul Won Choi	8
6	Genipin Enhances the Therapeutic Effects of Oxaliplatin by Upregulating BIM in Colorectal Cancer 2019 ·Molecular Cancer Therapeutics ·Bo Ram Kim, Yoon A Jeong, Min Jee Jo, Seong Hye Park, Yoo Jin Na, Jung Lim Kim, Soyeon Jeong, Hye Kyeong Yun, Sanghee Kang, Dae-Hee Lee, Sang Cheul Oh	18
7	Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer 2019 ·BMC Cancer ·Min Jee Jo, Soyeon Jeong, Hye Kyeong Yun, Dae Yeong Kim, Bo Ram Kim, Jung Lim Kim, Yoo Jin Na, Seong Hye Park, Yoon A Jeong, Bu Gyeom Kim, Hassan Ashktorab, Duane T. Smoot, Jun Young Heo, Jeongsu Han, Dae-Hee Lee, Sang Cheul Oh	37
8	Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells 2019 ·Cancer Letters ·Soyeon Jeong, Hye Kyeong Yun, Yoon A Jeong, Min Jee Jo, Sanghee Kang, Jung Lim Kim, Dae Yeong Kim, Seong Hye Park, Bo Ram Kim, Yoo Jin Na, Sun Il Lee, Han Do Kim, Dae Hyun Kim, Sang Cheul Oh, Dae-Hee Lee	125
9	Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer 2019 ·Oncogene ·Seong Hye Park, Soyeon Jeong, Bo Ram Kim, Yoon A Jeong, Jung Lim Kim, Yoo Jin Na, Min Jee Jo, Hye Kyeong Yun, Dae Yeong Kim, Bu Gyeom Kim, Dae-Hee Lee, Sang Cheul Oh	32
10	Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer 2019 ·Theranostics ·Seong Hye Park, Min Jee Jo, Bo Ram Kim, Yoon A Jeong, Yoo Jin Na, Jung Lim Kim, Soyeon Jeong, Hye Kyeong Yun, Dae Yeong Kim, Bu Gyeom Kim, Sanghee Kang, Sang Cheul Oh, Dae-Hee Lee	28
11	RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer 2019 ·Oncogene ·Bo Ram Kim, Seong Hye Park, Yoon A Jeong, Yoo Jin Na, Jung Lim Kim, Min Jee Jo, Soyeon Jeong, Hye Kyeong Yun, Sang Cheul Oh, Dae-Hee Lee	30
12	RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer 2019 ·Cell Death and Differentiation ·Bo Ram Kim, Yoo Jin Na, Jung Lim Kim, Yoon A Jeong, Seong Hye Park, Min Jee Jo, Soyeon Jeong, Sanghee Kang, Sang Cheul Oh, Dae-Hee Lee	57
13	Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer 2019 ·Cell Death and Disease ·Soyeon Jeong, Min Jee Jo, Hye Kyeong Yun, Dae Yeong Kim, Bo Ram Kim, Jung Lim Kim, Seong Hye Park, Yoo Jin Na, Yoon A Jeong, Bu Gyeom Kim, Hassan Ashktorab, Duane T. Smoot, Jun Young Heo, Jeongsu Han, Sun Il Lee, Han Do Kim, Dae‐Hyun Kim, Sang Cheul Oh, Dae-Hee Lee	69
14	Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients 2018 ·OncoTargets and Therapy ·Hong Jun Kim, Min Jee Jo, Bo Ram Kim, Jung Lim Kim, Yoon A Jeong, Yoo Jin Na, Seong Hye Park, Suk‐young Lee, Dae‐Hee Lee, Baek‐hui Kim, Young Yoo, Sang Cheul Oh	19
15	Upregulation of EphB3 in gastric cancer with acquired resistance to a FGFR inhibitor 2018 ·The International Journal of Biochemistry & Cell Biology ·Suk‐young Lee, Yoo Jin Na, Yoon A Jeong, Jung Lim Kim, Sang Cheul Oh, Dae-Hee Lee	22
16	Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients 2017 ·PLoS ONE ·Hong Jun Kim, Min Jee Jo, Bo Ram Kim, Jung Lim Kim, Yoon A Jeong, Yoo Jin Na, Seong Hye Park, Suk‐young Lee, Dae‐Hee Lee, Hye Seung Lee, Baek‐hui Kim, Sun Il Lee, Byung Wook Min, Young Do Yoo, Sang Cheul Oh	28
17	Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation 2017 ·The International Journal of Biochemistry & Cell Biology ·Yoo Jin Na, Dae-Hee Lee, Jung Lim Kim, Bo Ram Kim, Seong Hye Park, Min Jee Jo, Soyeon Jeong, Hong Jun Kim, Suk‐young Lee, Yoon A Jeong, Sang Cheul Oh	18
18	Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells 2016 ·The Korean Journal of Internal Medicine ·Dae Sik Kim, Yoo Jin Na, Myoung Hee Kang, Soo‐Young Yoon, Chul Won Choi	9
19	RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer 2016 ·Oncology Reports ·Bo Ram Kim, Myoung Hee Kang, Jung Lim Kim, Yoo Jin Na, Seong Hye Park, Sun Il Lee, Sanghee Kang, (unknown), Suk‐young Lee, Dae-Hee Lee, Byung Wook Min, Sang Cheul Oh	24
20	Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells 2016 ·Tumor Biology ·Jung Lim Kim, Dae-Hee Lee, Yoo Jin Na, Bo Ram Kim, Yoon A Jeong, Sun Il Lee, Sanghee Kang, (unknown), Suk‐young Lee, Sang Cheul Oh, Byung Wook Min	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact